Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: Fulvestrant|DRUG: Vandetanib
Sponsor: Velindre NHS Trust
Collaborators: Cancer Research UK|AstraZeneca